Experts warn that disruptions from the Iran conflict could take months for global pharmaceutical supply chains to stabilise. Active pharmaceutical ingredients, the key raw materials used to manufacture medicines, are expected to see only gradual relief. The delayed recovery may contribute to longer-lasting cost pressures across the medicines ecosystem, depending on how quickly routes, contracts, and inventories normalise.
Swipe through stories, personalise your feed, and save articles for later — all on the app.
